Treatment Approaches for Encephalopathy and Delirium

Understanding the Distinction

Delirium is defined as an acute disorder of cognition and attention, often occurring during medical illness or after surgery, characterized by acute onset and fluctuating course 1
Encephalopathy is a broader term often used interchangeably with delirium in clinical settings, but typically refers to brain dysfunction with an identifiable organic or metabolic cause 3
The terms are sometimes used interchangeably, with "encephalopathy" often preferred when a primary etiology is identified, while "delirium" may be used when the condition is multifactorial 3

Both conditions require assessment for underlying causes, but with different diagnostic emphases 2, 4
Delirium diagnosis relies on validated tools like the Confusion Assessment Method (CAM) or DSM-5 criteria 2, 5
Encephalopathy diagnosis often requires specific testing related to the suspected organ system dysfunction (e.g., ammonia levels in hepatic encephalopathy) 4
EEG can help differentiate between delirium and non-convulsive status epilepticus, which may present similarly 6

Hepatic encephalopathy treatment focuses on ammonia reduction strategies and addressing liver dysfunction 4
Brain imaging (CT or MRI) is recommended for encephalopathy when diagnostic doubts exist or when there's non-response to treatment 4
In hepatic encephalopathy, ammonia measurement has high negative predictive value; normal ammonia in a patient with cirrhosis and delirium should prompt investigation for other causes 4

Non-pharmacological interventions should be maximized before considering medications 7, 5
Implement reorientation strategies, cognitive stimulation, and sleep hygiene measures 5
For moderate delirium, oral antipsychotics such as quetiapine, olanzapine, or aripiprazole may be considered 7, 5
For severe delirium with agitation, antipsychotic medications like haloperidol, olanzapine, or chlorpromazine are recommended 7
Benzodiazepines should be avoided as initial treatment for delirium unless the patient is already taking them or experiencing alcohol withdrawal 7, 5

Hypoactive delirium is often underdiagnosed but is the most prevalent subtype in palliative care patients 7, 5
Hyperactive delirium typically requires more aggressive pharmacological management 7
For delirium in patients with advanced disease and limited life expectancy, focus on symptom management and family support 7
Alpha-2 agonists may promote sleep and have beneficial effects in ICU patients 6
Daily interruption of sedation and early mobilization may help prevent or reduce delirium 6